Loading clinical trials...
Loading clinical trials...
Hyperbaric Oxygen Therapy as Salvage Therapy for Healthy, Severely Injured, Mechanically Ventilated Invasive Fungal Infection Cases Resistant to Therapy
The goal of this observational study is to learn about the effects of Hyperbaric Oxygen Therapy on healthy individual who suffer from invasive fungal infection caused by severe trauma, who do not respond to conventional treatment. The main question it aims to answer is: Does the treatment aid in eradicating the infection and improve the overall outcome of such patients?
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Shamir Medical Center
Ẕerifin, Israel
Start Date
August 4, 2024
Primary Completion Date
December 1, 2025
Completion Date
December 1, 2025
Last Updated
August 13, 2025
7
ACTUAL participants
Hyperbaric Oxygen Therapy
OTHER
Lead Sponsor
Assaf-Harofeh Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05688592